David HobsonUK & European Patent Attorney
David joined Mathys & Squire in 2015 having previously worked for another private-practice Intellectual Property firm. He has a background in biochemistry.
David acts for UK and overseas biotechnology, pharmaceutical, and food/beverage clients, as well as SMEs and academic institutions in all patent matters.
Year joined: 2015
Qualifications: BSc, PhD, Certificate In IP Law, EPA, CPA
David has extensive patent drafting and multi-jurisdictional prosecution experience. He is also experienced at providing therapeutic freedom to operate and validity advice, as well as handling opposition proceedings before the EPO. Some key hearings include: “Recombinant EPO” (Sterrenbeld Biotechnologie; Polymun Scientific Immunbiologische) and “Modified Clostridial Neurotoxins” (Ipsen Bioinnovation; Merz Pharma).
Building on his in-depth knowledge of biochemistry much of the patent work he performs relates to enzyme biotechnology, including its application in the food and pharmaceutical industries, as well as antibody therapeutics, plant biotechnology and associated rights, such as Plant Variety Rights.
David has a PhD in Biochemistry from the Cancer Research UK London Research Institute (awarded by UCL). His PhD was in the field of transcription and enzyme mechanisms, specifically. Click here for more information.
Membership & Organisations
European Patent Attorney;
Chartered UK Patent Attorney;
Fellow of the Chartered Institute of Patent Attorneys
David has co-authored a number of publications and a link to these publications is below.
- Patent Drafting and Filing
- Patent Enforcement
- Patent Portfolio Management
- Patent Oppositions
- IP Strategy
- Freedom to Operate
- Due Diligence